Cargando…
The methylation modification of m6A regulators contributes to the prognosis of ovarian cancer
BACKGROUND: Ovarian cancer (OV) is the leading cause of death in gynecological cancer. The dysregulation of N6-methyladenosine (m6A) modification is commonly found in cancers. However, there is a lack of research into m6A RNA methylation regulators in OV. METHODS: The RNA-Seq of 379 OV tissues and 8...
Autores principales: | Zhu, Wenjing, Zhao, Long, Kong, Beihua, Liu, Ying, Zou, Xin, Han, Tongqin, Shi, Yongmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848366/ https://www.ncbi.nlm.nih.gov/pubmed/35282121 http://dx.doi.org/10.21037/atm-21-6462 |
Ejemplares similares
-
A Panel of E2F Target Gene Signature Predicting the Prognosis of Hepatocellular Carcinoma
por: Hu, Wenmin, et al.
Publicado: (2022) -
The methylation modification of m6A regulators contributes to the prognosis of head and neck squamous cell carcinoma
por: Chen, Ying, et al.
Publicado: (2021) -
Emerging role of m6A methylation modification in ovarian cancer
por: Chang, Lin-Lin, et al.
Publicado: (2021) -
Reduced m(6)A mRNA methylation is correlated with the progression of human cervical cancer
por: Wang, Xiuli, et al.
Publicado: (2017) -
Genetic Analyses Support the Contribution of mRNA N(6)-methyladenosine (m(6)A) Modification to Human Disease Heritability
por: Zhang, Zijie, et al.
Publicado: (2020)